Skip to main content
Clinical Trials/NCT06386978
NCT06386978
Completed
Not Applicable

Examination of the Postoperative Analgesic Efficacy of Transvers Abdominis Plane Block and Transversalis Fascia Plane Block in Cesarean Section Surgeries Performed Under Spinal Anesthesia

TC Erciyes University1 site in 1 country90 target enrollmentMay 30, 2025
ConditionsObstetric

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstetric
Sponsor
TC Erciyes University
Enrollment
90
Locations
1
Primary Endpoint
VAS score evaluation
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

This study was designed as a prospective, randomized observational clinical trial.

A total of 90 adult women were included in the study performed elective cesarean section.

After excluding patients, the care of 90 was included and 3 of these amounts were reserved.

TAP Block Group (n=30,Group 1): Spinal Anesthesia + TAP block ; TFP Block group (n=30,Group 2): Spinal Anesthesia + TFP block ; Control group (n=30,Group 3); Spinal Anesthesia + No block;

Detailed Description

This study was designed as a prospective, randomized observational clinical trial. Erciyes University Clinical Research Ethics Board 2024/209. All participants in the study were adults and their information was confirmed in writing. Preoperative anesthesia assessment was made by an anesthetic injection, cesarean section surgeries for 90 women were planned to be performed on elective conditions among those registered between May 2024 and May 2025. ASA score, anesthesia method, age, weight, height, TAP block group (Group I) or TFP block group (Group II), Control group (Group III) : Duration of spinal anesthesia, time of first analgesic request, total analgesic consumption for 24-48 hours, VAS score, additional analgesics, patient satisfaction, possible postoperative bleeding, vomiting, heat retention and other interruptions were recorded in the patients. Those who were allergic to local anesthetics, steroid treatment areas, ASA III, ASA IV and ASA V, patients under the age of 18, preeclampsia, eclampsia, placenta percreta and accreta complications and emergency hospitals were excluded from the study. After excluding patients, the care of 90 was included and 3 of these amounts were reserved. TAP Block Group (n=30,Group 1): Spinal Anesthesia + TAP block ; TFP Block group (n=30,Group 2): Spinal Anesthesia + TFP block ; Control group (n=30,Group 3): Spinal Anesthesia + No block; At the end of the surgery, TAP (Transverse Abdominis Plane Block) Block or TFP (Transversalis Fascia Plane Block) block was performed under aseptic conditions under ultrasonography guidance. TAP (Transverse Abdominis Plane Block) Block for Group 1 patients and TFP (Transversalis Fascia Plane Block) block for Group 2 patients on both sides after negative aspiration, with 20 ml 0.25% bupivacaine (Marcaine®, Astra-Zeneca, Turkey) under ultrasonography guidance. It was done under aseptic conditions. Patients who did not accept both blocks were included in Group 3 (Control group). All patients were trained on visual analog score (VAS) by the anesthesia assistant during the preoperative evaluation. VAS used for pain assessment, a 10 cm long horizontal line was used. From 0= (no pain) to 10= (most severe pain). PCA morphine administration to all patients: The hourly limit was set as 4 mg, and the repeat limit was set as 10 minutes. If the 1 mg IV morphine bolus dose was not sufficient, it was planned to repeat it after 10 minutes, and if it was still not sufficient, paracetamol and diclofenac were planned to be administered.

Registry
clinicaltrials.gov
Start Date
May 30, 2025
End Date
December 15, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kudret Dogru

Prof. Dr.

TC Erciyes University

Eligibility Criteria

Inclusion Criteria

  • ASA I and ASA II,
  • Pregnant patients accepting spinal anesthesia and procedure

Exclusion Criteria

  • Those who are allergic to local anesthetics,
  • Those receiving steroid treatment,
  • ASA III, ASA IV and ASA V,
  • Patients under the age of 18,
  • Patients with preeclampsia,
  • Eclampsia,
  • Placenta percreta and accreta and its complications,
  • Emergency patients.

Outcomes

Primary Outcomes

VAS score evaluation

Time Frame: 1st, 6th, 12nd, 24 hours at rest, in the first 24hr first day of postoperative period.

A research asistant, bilinded to the group allocation, interviewedpatients and collected data in the24 hours postoperative period. Verbal Analog Pain Scale Score value will be the lowerst 0 and the highest 10. All the highest value, the patient's pain is at its maximum and whether higher scores mean worse outcome.

Secondary Outcomes

  • time until the first analgesic request(1st, 6th, 12nd, 24 hours at rest, in the first 24hr first day of postoperative period)

Study Sites (1)

Loading locations...

Similar Trials